Japanese Journal of Veterinary Anesthesia & Surgery
Online ISSN : 1349-7669
Print ISSN : 0916-5908
ISSN-L : 0916-5908
Volume 38, Issue 2
Displaying 1-3 of 3 articles from this issue
ORIGINAL
  • Kohsaku CHIJIWA, Ryohei NISHIMURA, Naoaki MATSUKI, Nobuo SASAKI
    2007 Volume 38 Issue 2 Pages 19-24
    Published: 2007
    Released on J-STAGE: April 02, 2008
    JOURNAL FREE ACCESS
    Clinical features and relationship between treatment and prognosis were evaluated in 22 canine insulinomas. Nineteen dogs were middle or small-sized dogs weighing less than 20 kg, indicating a different tendency compared to several reports that large-breed dogs were commonly affected. Metastases were observed in 11 (69%) of 16 dogs surgically treated and the metastatic rate was higher than the past reports. One-year survival rate (56%) in dogs treated surgically was compatible with several reports and there is no difference of the survival interval compared to dogs treated medically alone. However, disease-free interval was significantly longer than that of dogs treated medically alone (P=0.0099). The clinical signs recurred within 3 months in 5 of 6 dogs treated medically alone. In addition, the result of the side effects by steroid and diazoxide may support a view that a medical treatment alone was not expected to a good quality of life. In conclusion, surgical treatment aimed at reducing tumor mass volume is useful for canine insulinoma unless there are diffuse metastases to the other organs.
    Download PDF (307K)
BRIEF NOTE
LECTURE
feedback
Top